TORONTO--(BUSINESS WIRE)--July 25, 2005--Swiss Medica, Inc's (OTCBB:SWME) second quarter revenues grew to a record US$1.38 million - an increase of more than 22 percent over the Company's first...
Swiss Medica Welcomes Experienced Health Industry Professional Charles Orr to Board of Directors
After 18 months as chairman of the company's Board of Advisors, Mr. Orr deepens his commitment to...
Swiss Medica's O24 Pain Neutralizer adds New Retailers
TORONTO
Swiss Medica Inc.
David Jones
Investor Relations Contact:
(866) 485-4243
OR
Blue Skye PR, Inc.
Sky Wallen
Product PR...
Swiss Medica Issues Store Count Guidance for O24 Pain Neutralizer Product
TORONTO
Swiss Medica Inc.
Investor Relations Contact:
David Jones
(866) 485-4243
OR
Blue Skye PR, Inc.
Product PR...
Swiss Medica Announces Six-Figure Mexican Distribution Agreement
TORONTO
Swiss Medica Inc.
Investor Relations Contact:
David Jones
(866) 485-4243
OR
Blue Skye PR, Inc.
Product PR Contact:...
Swiss Medica Retains Stern & Co. To Launch Comprehensive Financial Media Relations Campaign
NEW YORK
Swiss Medica Inc.
Investor Relations Contact:
David Jones
(866) 485-4243
OR
Blue Skye...
Swiss Medica Announces Vice President in Charge of Anti-Depression Biohealth Solutions Division
TORONTO
Investor Relations Contact:
David Jones
Swiss Medica Inc.
1 (866) 485-4243
OR
Press...
Swiss Medica Launches Patented, Clinically Proven Product for Pre-Menstrual Syndrome
TORONTO
Investor Relations Contact:
David Jones
Swiss Medica Inc.
1 (866) 485-4243
OR
Press Contact:
...
Swiss Medica's First Quarter Revenues Surpass US $1 Million Level
TORONTO--(BUSINESS WIRE)--April 7, 2005--Swiss Medica Inc.'s (OTCBB:SWME) first quarter net revenues grew to $1.13 million for...
Swiss Medica Announces Strategic Alliance with MIT Scientists As Part of Recent Acquisition of Anti-Depression BioHealth Solutions Inc.
TORONTO--(BUSINESS WIRE)--April 6, 2005--Swiss Medica...
Swiss Medica, Inc. Acquires Anti-Depression BioHealth Solutions, Inc. From UTEK Corporation; Acquisition Complements Company's Flagship Product
TORONTO & PLANT CITY, Fla.
For Swiss Medica,...
Randomized Double Blind Clinical Study Shows Improvement for 90% of Fibromyalgia Patients Using Swiss Medica's O24 Pain Relief Product
TORONTO
Swiss Medica Inc.
Investor Relations Contact:
...
Swiss Medica's O24 Essential Oil Pain Neutralizer Surpasses 6,000-Store Level
TORONTO
Swiss Medica Inc.
Investor Relations Contact:
David Jones
1 866 485 4243
OR
Blue Skye PR, Inc.
Press...
Photo Release -- Swiss Medica Leads O24 Ad Campaign with Savage Nation
TAMPA, Fla. March 16, 2005 (PRIMEZONE) -- Swiss Medica's (OTCBB:SWME) advertising launch for the O24(tm) pain reliever...
Swiss Medica Launches Multi-Media Advertising Campaign to Support U.S. Sales of O24 Essential Oil Pain Neutralizer
TORONTO
Swiss Medica Inc.
Investor Relations Contact:
David Jones
1 866 485...